Clinical Trial: A Study on the Efficacy and Safety of Sintilimab Combined With Ramucirumab and Paclitaxel in the Treatment of Gastric Cancer Patients With Short-term Recurrence After Adjuvant Therapy

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07669740) titled 'A Study on the Efficacy and Safety of Sintilimab Combined With Ramucirumab and Paclitaxel in the Treatment of Gastric Cancer Patients With Short-term Recurrence After Adjuvant Therapy' on Jan. 09.

Brief Summary: To explore the efficacy and safety of sintilimab combined with ramucirumab and paclitaxel in the treatment of advanced gastric cancer patients with short-term recurrence after postoperative adjuvant therapy, and to identify efficacy-related biomarkers to guide subsequent individualized treatment.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Gastric Cancer (Diagnosis)

Intervention: DRUG: Sintilimab Co...